Pharmacyte Biotech Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$0.55

+0.00 (+0.18%)

As of Aug 15, 2:36 AM ET ·

Analyst Consensus

Strong Sell

Analysts

Moderate

Coverage

Buy 0 0%

Hold 3 50%

Sell 3 50%

Price Target

Analyst Price Target +4,932.7% upside

Low Target $20.43

Average Target $27.73

High Target $35.07

Current Price $0.55

Current
$0.55

Target
$27.73

$20.43 $27.73 avg $35.07

Scenario Analysis

Bear Case

$20.43

3,607.8%

Low target

Base Case

$27.73

+4,932.7%

Avg target

Bull Case

$35.07

+6,264.8%

High target

Risk/Reward

1.7x

Balanced

Price in Context

52-Week High

$1.51

-63.5% from high

52-Week Low

$0.53

+4.0% from low

Target vs 52W High

$27.73

+1,736.4% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	38	82%	$257.58	+3.3%
AMGN Amgen Inc	Hold	43	49%	$190.87	-54.0%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+162.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	37	81%	$438.34	-13.3%
REGN Regeneron Pharmaceuticals	Buy	37	70%	$76.80	-90.4%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-53.9%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-44.0%
BIIB Biogen Inc	Buy	43	67%	$91.45	-56.4%